Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Clinical Trials of Cancer Immunotherapies

Abstract A016: PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8+ T-cell invigoration and polyclonal T-cell expansion in cancer patients

Martin Oft, Aung Naing, Jeffrey R. Infante, Kyriakos P. Papadopoulos, Ivan H. Chan, Cong Shen, Navneet P. Ratti, Karen A. Autio, Deborah J. Wong, Manish R. Patel, Patrick A. Ott, Gerald S. Falchook, Shubham Pant, Annie Hung, John B. Mumm, Matthew Adamow, Scott McCauley, Rakesh Verma, Phillip Wong, Peter VanVlasselaer, Joseph Leveque and Nizar M. Tannir
Martin Oft
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aung Naing
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey R. Infante
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyriakos P. Papadopoulos
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan H. Chan
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cong Shen
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Navneet P. Ratti
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen A. Autio
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah J. Wong
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manish R. Patel
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick A. Ott
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald S. Falchook
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shubham Pant
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie Hung
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John B. Mumm
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Adamow
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott McCauley
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakesh Verma
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phillip Wong
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter VanVlasselaer
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Leveque
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nizar M. Tannir
ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/2326-6074.CRICIMTEATIAACR18-A016 Published February 2019
  • Article
  • Info & Metrics
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: January 2019 to February 2021

AbstractFull-text HTMLPDF
Total35000

Cited By

Article Information

Volume 7, Issue 2 Supplement, pp. A016

DOI 
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A016

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074

Copyright & Usage 
©2019 American Association for Cancer Research.

Author Information

  1. Martin Oft,
  2. Aung Naing,
  3. Jeffrey R. Infante,
  4. Kyriakos P. Papadopoulos,
  5. Ivan H. Chan,
  6. Cong Shen,
  7. Navneet P. Ratti,
  8. Karen A. Autio,
  9. Deborah J. Wong,
  10. Manish R. Patel,
  11. Patrick A. Ott,
  12. Gerald S. Falchook,
  13. Shubham Pant,
  14. Annie Hung,
  15. John B. Mumm,
  16. Matthew Adamow,
  17. Scott McCauley,
  18. Rakesh Verma,
  19. Phillip Wong,
  20. Peter VanVlasselaer,
  21. Joseph Leveque, and
  22. Nizar M. Tannir
  1. ARMO BioSciences, Redwoood City, CA; University of Texas MD Anderson Cancer Center, Houston, TX; SCRI, Nashville, TN; START, San Antonio, TX; Memorial Sloan Kettering Cancer Center, New York, NY; UCLA, Los Angeles, CA; Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Dana-Farber Cancer Institute, Boston, MA; Sarah Cannon Research Institute at HealthONE, Denver, CO.
Previous
Back to top
Cancer Immunology Research: 7 (2 Supplement)
February 2019
Volume 7, Issue 2 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract A016: PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8+ T-cell invigoration and polyclonal T-cell expansion in cancer patients
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract A016: PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8+ T-cell invigoration and polyclonal T-cell expansion in cancer patients
Martin Oft, Aung Naing, Jeffrey R. Infante, Kyriakos P. Papadopoulos, Ivan H. Chan, Cong Shen, Navneet P. Ratti, Karen A. Autio, Deborah J. Wong, Manish R. Patel, Patrick A. Ott, Gerald S. Falchook, Shubham Pant, Annie Hung, John B. Mumm, Matthew Adamow, Scott McCauley, Rakesh Verma, Phillip Wong, Peter VanVlasselaer, Joseph Leveque and Nizar M. Tannir
Cancer Immunol Res February 1 2019 (7) (2 Supplement) A016; DOI: 10.1158/2326-6074.CRICIMTEATIAACR18-A016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract A016: PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8+ T-cell invigoration and polyclonal T-cell expansion in cancer patients
Martin Oft, Aung Naing, Jeffrey R. Infante, Kyriakos P. Papadopoulos, Ivan H. Chan, Cong Shen, Navneet P. Ratti, Karen A. Autio, Deborah J. Wong, Manish R. Patel, Patrick A. Ott, Gerald S. Falchook, Shubham Pant, Annie Hung, John B. Mumm, Matthew Adamow, Scott McCauley, Rakesh Verma, Phillip Wong, Peter VanVlasselaer, Joseph Leveque and Nizar M. Tannir
Cancer Immunol Res February 1 2019 (7) (2 Supplement) A016; DOI: 10.1158/2326-6074.CRICIMTEATIAACR18-A016
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Clinical Trials of Cancer Immunotherapies

  • Abstract A007: Comparison of pretreatment conditioning on efficacy in two cohorts of a pilot study of genetically engineered NY-ESO-1c259T-cells in patients with synovial sarcoma
  • Abstract A010: Personalized neoantigen-targeting vaccines for high-risk melanoma generate epitope spreading
  • Abstract A006: Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, durva) + tremelimumab (treme) in patients with advanced solid tumors
Show more Clinical Trials of Cancer Immunotherapies

Clinical Trials of Cancer Immunotherapies: Poster Presentations - Proffered Abstracts

  • Abstract A007: Comparison of pretreatment conditioning on efficacy in two cohorts of a pilot study of genetically engineered NY-ESO-1c259T-cells in patients with synovial sarcoma
  • Abstract A010: Personalized neoantigen-targeting vaccines for high-risk melanoma generate epitope spreading
  • Abstract A006: Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, durva) + tremelimumab (treme) in patients with advanced solid tumors
Show more Clinical Trials of Cancer Immunotherapies: Poster Presentations - Proffered Abstracts
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement